Home › Post-Traumatic Stress Disorder › NCT07260032
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
Recruiting
Using Advanced Imaging to Determine the Benefits of Exercise on Cardiovascular Risk in PTSD
Who can join
Ages 18 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 18-65 years * Trauma exposure * PTSD symptoms * Subclinical atherosclerotic CVD (e.g., coronary, cerebrovascular, or peripheral arterial plaque or calcifications on imaging), clinical atherosclerotic CVD (e.g., myocardial infarction or revascularization), or increased risk for atherosclerotic CVD (i.e., \>2 of hypertension, diabetes mellitus, hyperlipidemia, and active smoking) * Ability to understand and sign informed consent Exclusion Criteria: * History of stroke, brain surgery, or seizure * Use of certain CVD medications (e.g., beta-blockers, high-intensity statins \[e.g., rosuvastatin 20/40 mg and atorvastatin 40/80 mg\], PCSK-9 inhibitors) * Psychiatric or cardiovascular medication change within 4 weeks (i.e., stable regimen is allowed) * Unstable blood pressure or cardiac arrhythmia * Currently in a supervised or graduated exercise program * Neurological or systemic inflammatory disease/current systemic anti-inflammatory therapy * Moderate/severe alcohol/substance use disorder * Current mania/psychosis * Weight \>300 lbs. * Claustrophobia * Pregnancy * Metal implants * Uncontrolled hyperglycemia (HgbA1c\>7.5%) * Subjects who have had significant radiation exposure as part of research (\>2 nuclear tests, computed tomography images, or fluoroscopic procedures) during the preceding 12-months
About the study
The purpose of this study is to use a non-invasive imaging technique called positron emission tomography/magnetic resonance imaging (PET/MRI) to investigate the effects of exercise on brain activity and arterial (blood vessel) inflammation in people with PTSD symptoms and evidence of or elevated risk for artery disease.
What is being tested
- Exercise (behavioral)
Sponsor: Massachusetts General Hospital · Participants: 10 · Started: Feb 1, 2025
Contact the study team
- Antonia Seligowski, PhD · Phone: 617-643-0954
Official record on ClinicalTrials.gov — NCT07260032
Locations in the U.S.
| Massachusetts | Massachusetts General Hospital, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.